Ligand Pharmaceuticals (LGND) Tmuɣli n wazal
Ligand Pharmaceuticals
Ṛṛbem n lḥedd$301.89Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel+0.95%
Asnulfu n AI: LGND
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Ligand Pharmaceuticals Incorporated develops drugs that regulate intracellular receptors activated by hormones that help control genetic processes affecting diseases, such as gynecological disorders, some types of cancer, cardiovascular, inflammatory and skin diseases.
